Sep 10, 2026 08:00AM
Aug 24, 2026 08:03AM
Aug 24, 2026 08:00AM
Aug 17, 2026 08:00AM
Aug 17, 2026 08:00AM
Aug 11, 2026 08:00AM
Aug 11, 2026 08:00AM  Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired H
Aug 4, 2026 04:01PM
Aug 4, 2026 07:01AM
Aug 4, 2026 06:55AM
Aug 4, 2026 06:55AM
Jul 21, 2026 08:00AM
Jul 8, 2026 05:07PM
Jul 8, 2026 05:07PM Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity
Jul 1, 2026 12:00PM
Jun 15, 2026 04:01PM
Jun 15, 2026 04:01PM
Jun 15, 2026 09:31AM
Jun 13, 2026 08:01AM
Jun 13, 2026 08:01AM
Jun 12, 2026 04:01PM Rhythm Pharmaceuticals schedules call on Prader-Willi syndrome trial data
Jun 12, 2026 04:01PM
Jun 3, 2026 04:43AM
May 29, 2026 08:00AM
May 28, 2026 08:00AM
May 26, 2026 08:00AM
May 12, 2026 08:00AM
May 6, 2026 08:00AM Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
May 5, 2026 07:00AM
May 4, 2026 08:00AM
May 1, 2026 06:55AM
May 1, 2026 06:55AM
Apr 19, 2026 10:00AM
Apr 9, 2026 08:00AM
Apr 3, 2026 09:00AM Rhythm Pharmaceuticals appoints Kim Popovits to board
Apr 3, 2026 09:00AM
Mar 26, 2026 02:50PM
Mar 26, 2026 09:02AM
Mar 26, 2026 09:01AM
Mar 23, 2026 06:45AM
Mar 19, 2026 06:30PM
Mar 19, 2026 06:30PM Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
Mar 17, 2026 08:13AM
Mar 16, 2026 04:01PM
Mar 16, 2026 04:01PM
Mar 2, 2026 06:43AM
Mar 1, 2026 12:30PM
Mar 1, 2026 12:30PM
Feb 27, 2026 06:54AM Rhythm Pharmaceuticals (RYTM) PT Raised to $143 at Guggenheim
Feb 26, 2026 07:00AM

330,677 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All